Paul A Mahon United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

Paul A Mahon is EVP & GENERAL COUNSEL of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 36,781 shares of UTHR, which is worth approximately $11.5 Million. The most recent transaction as insider was on Feb 03, 2022, when has been sold 6,000 shares (Common Stock) at a price of $200.03 per share, resulting in proceeds of $1,200,180. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.8K
0.19% 3M change
0.19% 12M change
Total Value Held $11.5 Million

PAUL A MAHON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2022
SELL
Open market or private sale
$1,200,180 $200.03 p/Share
6,000 Reduced 16.5%
30,369 Common Stock
Feb 03 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 14.16%
36,369 Common Stock
Jan 20 2022
SELL
Open market or private sale
$1,234,260 $205.71 p/Share
6,000 Reduced 16.5%
30,369 Common Stock
Jan 20 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 14.16%
36,369 Common Stock
Jan 06 2022
SELL
Open market or private sale
$1,151,280 $191.88 p/Share
6,000 Reduced 16.5%
30,369 Common Stock
Dec 16 2021
SELL
Open market or private sale
$1,171,140 $195.19 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Dec 16 2021
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Dec 02 2021
SELL
Open market or private sale
$1,135,620 $189.27 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Dec 02 2021
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Nov 18 2021
SELL
Sale (or disposition) back to the issuer
$1,194,060 $199.01 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Nov 18 2021
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Nov 04 2021
SELL
Open market or private sale
$1,210,260 $201.71 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Nov 04 2021
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Oct 21 2021
SELL
Open market or private sale
$1,141,080 $190.18 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Oct 21 2021
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Oct 07 2021
SELL
Open market or private sale
$1,145,160 $190.86 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Oct 07 2021
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Sep 16 2021
SELL
Open market or private sale
$1,222,740 $203.79 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Sep 16 2021
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Sep 02 2021
SELL
Open market or private sale
$1,269,840 $211.64 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Sep 02 2021
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Aug 23 2021
SELL
Open market or private sale
$1,237,080 $206.18 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Aug 23 2021
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Aug 05 2021
SELL
Sale (or disposition) back to the issuer
$1,129,810 $205.42 p/Share
5,500 Reduced 13.14%
36,369 Common Stock
Aug 05 2021
BUY
Exercise of conversion of derivative security
$522,280 $94.96 p/Share
5,500 Added 11.61%
41,869 Common Stock
PAM

Paul A Mahon

EVP & GENERAL COUNSEL
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR